Lotus says the stake marks its first foray into the dermaceutical segment
Indian natural beauty company Lotus Herbals has bought a 32% strategic stake in Fixderma India, owner of the Fixderma and FCL brands.
According to Lotus, the share purchase marks its first move into the dermaceutical segment, offering premium skin care and hair care products that bridge prescription-based and over-the-counter goods.
Fixderma and its premium skin care range FCL are said to focus on innovative dermatology products working alongside renowned dermatologists in India and exporting to over 35 countries across the globe.
Nitin Passi, Joint Managing Director of Lotus Herbals, commented: “Over the past 27 years Lotus has always been an innovation leader in the beauty industry.
"We are delighted to partner with Fixderma as their brand philosophy, ethics and diversified range of world class dermaceutical products fit perfectly with the values and experimental blueprint of Lotus.
“With our strategic planning and marketing expertise, we aim at enhancing the global footprint for Fixderma and FCL and capture significant market share within the next five years as part of our long-term growth strategy.”
“Lotus Herbals has a strong and successful history in the beauty industry and we are confident that the expertise and experience Lotus Herbals brings will ensure greater success for our brands,” added Anurag Mehrotra, Chairman, Fixderma India.
“Developments in the Indian skin care industry are exciting and challenging, especially in the e-commerce space, however, the engagement level, passion and experiential resonance our customers have with our brands is amazing.
“We are thrilled to partner with Lotus to help strategically optimise this in a meaningful way.”